We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Fortive to Report Q3 Earnings: What's in Store for the Stock?
Read MoreHide Full Article
Key Takeaways
Fortive is set to report Q3 earnings on Oct. 28, with revenues expected to rise 3% and EPS to grow 2.94%.
Strong demand for Fluke's data center solutions and recurring services may boost Q3 results.
FTV faces pressures from unfavorable product mix, higher growth investments and cautious hospital spending.
Fortive Corporation (FTV - Free Report) is scheduled to report third-quarter 2026 results on Oct. 28.
The Zacks Consensus Estimate for revenues is pegged at $1.06 billion, which implies an increase of 3% from the year-ago reported number. The consensus mark for earnings is pegged at 70 cents per share, indicating year-over-year growth of 2.94%.
FTV’s earnings outpaced the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 9.82%.
Fortive is expected to have benefited from sustained momentum across its industrial technologies, software and healthcare businesses, supported by healthy demand for data center solutions, AI-enabled offerings and recurring services. The company continues to execute its Fortive Accelerated strategy, focusing on faster profitable organic growth through innovation, commercial investments and recurring customer value, alongside disciplined capital allocation.
The company is witnessing healthy demand across its Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS) segments. Within IOS, Fluke continues to benefit from robust demand for professional instrumentation, particularly in data centers and defense. Strong adoption of CertiFiber Max, which supports high-density fiber testing, is driving demand for Fluke's broader portfolio of network testing, power quality and battery testing solutions. Fluke's orders outpaced revenues in the second quarter, with a book-to-bill ratio above one, indicating healthy demand momentum.
The Facilities and Asset Lifecycle Solutions business is benefiting from strong demand for multisite facility maintenance and marketplace software, particularly at ServiceChannel. Improving performance at Accruent, solid contributions from Gordian and growing adoption of AI-enabled software offerings are likely to have supported third-quarter revenues. Strength in recurring services, including Fluke's calibration, maintenance and software offerings, remains another positive.
Within AHS, Fortive is benefiting from sustained demand for healthcare consumables, services and software solutions. ASP's consumables and services business recorded growth across all major regions in the second quarter, particularly the Asia-Pacific and Latin America. The low-temperature sterilization capital business also returned to growth amid gradually improving hospital spending conditions.
Moreover, FDA clearance for STERRAD's expanded 50-pound load capacity has strengthened ASP's position in robotic-assisted surgery applications. The acquisition of a majority stake in UV Smart further expands its disinfection portfolio. Strong demand for Provation's gastrointestinal documentation and SaaS offerings is another positive. These factors are expected to have supported the segment's third-quarter performance.
The Zacks Consensus Estimate for sales of the IOS and AHS segments is pegged at $733 million and $338 million, respectively, for the third quarter.
Fortive's operational discipline, structural cost savings and Fortive Business System-led productivity initiatives continue to support profitability. The company delivered 12% adjusted EBITDA growth and 110 basis points of adjusted EBITDA margin expansion in the second quarter. Continued cost optimization, operating leverage and disciplined capital allocation, including share repurchases, are likely to have supported third-quarter earnings.
However, Fortive expects third-quarter adjusted EBITDA margin to decline slightly sequentially due to seasonally lower revenues, strategic growth investments and tougher year-over-year operating expense comparisons. Unfavorable product mix across both segments is also expected to have pressured gross margins. Macroeconomic uncertainty in Europe, supply-chain challenges involving memory chips and rare-earth materials, and cautious hospital capital spending remain concerns. Management expects third-quarter adjusted earnings per share to increase marginally year over year, with earnings growth weighted toward the fourth quarter.
What Does Our Model Unveil for FTV?
Our proven model does not predict an earnings beat for Fortive this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the odds of an earnings beat. That is not the case here.
Fortive has an Earnings ESP of +0.58% and a Zacks Rank #4 (Sell) at present. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks to Consider
Here are a few stocks that you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this season.
STX is scheduled to report quarterly figures on Oct. 27, 2026. The Zacks Consensus Estimate for Seagate Technology’s to-be-reported quarter’s earnings and revenues is pinned at $7.44 per share and $4.11 billion, respectively. Its shares are up 175.4% in the past year.
Intel (INTC - Free Report) currently has an Earnings ESP of +2.22% and a Zacks Rank #2. INTC is scheduled to report quarterly earnings on Oct. 29, 2026. The Zacks Consensus Estimate for Intel’s to-be-reported quarter’s earnings and revenues stands at 39 cents per share and $16.44 billion, respectively. Its shares have gained 119.9% in the past year.
Vertiv (VRT - Free Report) has an Earnings ESP of +0.74% and a Zacks Rank #2 at present. The company is scheduled to report quarterly figures on Oct. 28, 2026. The Zacks Consensus Estimate for Vertiv’s to-be-reported quarter’s earnings and revenues is pinned at $1.82 per share and $3.76 billion, respectively. Its shares are up 0.8% in the past year.
View the Zacks #1 Rank List
Image: Bigstock
Fortive to Report Q3 Earnings: What's in Store for the Stock?
Key Takeaways
Fortive Corporation (FTV - Free Report) is scheduled to report third-quarter 2026 results on Oct. 28.
The Zacks Consensus Estimate for revenues is pegged at $1.06 billion, which implies an increase of 3% from the year-ago reported number. The consensus mark for earnings is pegged at 70 cents per share, indicating year-over-year growth of 2.94%.
FTV’s earnings outpaced the Zacks Consensus Estimate in each of the trailing four quarters, with the average surprise being 9.82%.
Fortive’s shares have gained 22.3% compared with the Electronics - Testing Equipment industry’s growth of 21.8% in the past year.
Image Source: Zacks Investment Research
Factors to Note Ahead of FTV’s Q3 Results
Fortive is expected to have benefited from sustained momentum across its industrial technologies, software and healthcare businesses, supported by healthy demand for data center solutions, AI-enabled offerings and recurring services. The company continues to execute its Fortive Accelerated strategy, focusing on faster profitable organic growth through innovation, commercial investments and recurring customer value, alongside disciplined capital allocation.
The company is witnessing healthy demand across its Intelligent Operating Solutions (IOS) and Advanced Healthcare Solutions (AHS) segments. Within IOS, Fluke continues to benefit from robust demand for professional instrumentation, particularly in data centers and defense. Strong adoption of CertiFiber Max, which supports high-density fiber testing, is driving demand for Fluke's broader portfolio of network testing, power quality and battery testing solutions. Fluke's orders outpaced revenues in the second quarter, with a book-to-bill ratio above one, indicating healthy demand momentum.
The Facilities and Asset Lifecycle Solutions business is benefiting from strong demand for multisite facility maintenance and marketplace software, particularly at ServiceChannel. Improving performance at Accruent, solid contributions from Gordian and growing adoption of AI-enabled software offerings are likely to have supported third-quarter revenues. Strength in recurring services, including Fluke's calibration, maintenance and software offerings, remains another positive.
Within AHS, Fortive is benefiting from sustained demand for healthcare consumables, services and software solutions. ASP's consumables and services business recorded growth across all major regions in the second quarter, particularly the Asia-Pacific and Latin America. The low-temperature sterilization capital business also returned to growth amid gradually improving hospital spending conditions.
Moreover, FDA clearance for STERRAD's expanded 50-pound load capacity has strengthened ASP's position in robotic-assisted surgery applications. The acquisition of a majority stake in UV Smart further expands its disinfection portfolio. Strong demand for Provation's gastrointestinal documentation and SaaS offerings is another positive. These factors are expected to have supported the segment's third-quarter performance.
The Zacks Consensus Estimate for sales of the IOS and AHS segments is pegged at $733 million and $338 million, respectively, for the third quarter.
Fortive Corporation Price and EPS Surprise
Fortive Corporation price-eps-surprise | Fortive Corporation Quote
Fortive's operational discipline, structural cost savings and Fortive Business System-led productivity initiatives continue to support profitability. The company delivered 12% adjusted EBITDA growth and 110 basis points of adjusted EBITDA margin expansion in the second quarter. Continued cost optimization, operating leverage and disciplined capital allocation, including share repurchases, are likely to have supported third-quarter earnings.
However, Fortive expects third-quarter adjusted EBITDA margin to decline slightly sequentially due to seasonally lower revenues, strategic growth investments and tougher year-over-year operating expense comparisons. Unfavorable product mix across both segments is also expected to have pressured gross margins. Macroeconomic uncertainty in Europe, supply-chain challenges involving memory chips and rare-earth materials, and cautious hospital capital spending remain concerns. Management expects third-quarter adjusted earnings per share to increase marginally year over year, with earnings growth weighted toward the fourth quarter.
What Does Our Model Unveil for FTV?
Our proven model does not predict an earnings beat for Fortive this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the odds of an earnings beat. That is not the case here.
Fortive has an Earnings ESP of +0.58% and a Zacks Rank #4 (Sell) at present. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks to Consider
Here are a few stocks that you may want to consider, as our model shows that these have the right combination of elements to post an earnings beat this season.
Seagate Technology Holdings plc (STX - Free Report) has an Earnings ESP of +2.07% and a Zacks Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
STX is scheduled to report quarterly figures on Oct. 27, 2026. The Zacks Consensus Estimate for Seagate Technology’s to-be-reported quarter’s earnings and revenues is pinned at $7.44 per share and $4.11 billion, respectively. Its shares are up 175.4% in the past year.
Intel (INTC - Free Report) currently has an Earnings ESP of +2.22% and a Zacks Rank #2. INTC is scheduled to report quarterly earnings on Oct. 29, 2026. The Zacks Consensus Estimate for Intel’s to-be-reported quarter’s earnings and revenues stands at 39 cents per share and $16.44 billion, respectively. Its shares have gained 119.9% in the past year.
Vertiv (VRT - Free Report) has an Earnings ESP of +0.74% and a Zacks Rank #2 at present. The company is scheduled to report quarterly figures on Oct. 28, 2026. The Zacks Consensus Estimate for Vertiv’s to-be-reported quarter’s earnings and revenues is pinned at $1.82 per share and $3.76 billion, respectively. Its shares are up 0.8% in the past year.